News
Hosted on MSN10mon
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information - MSNNorthvale, New Jersey–(Newsfile Corp. – August 14, 2024) – Elite Pharmaceuticals, Inc. (OTCQB: ELTP) (“Elite” or the “Company”), a specialty pharmaceutical company engaged in the ...
Elite Pharmaceuticals, Inc. ELTP reported breakeven earnings per share in the first quarter of fiscal 2025, flat year over year. Elite Pharmaceuticals registered revenues of $18.8 million in the ...
Elite Pharmaceuticals reported revenues of $18.9 million for the three months ... marking a 33.4% year-over-year increase. This robust growth was primarily driven by the Elite label product line.
Hosted on MSN12mon
Elite Pharmaceuticals' (ELTP) FY24 Earnings Up, Gross Margin Down - MSNElite Pharmaceuticals, Inc. ELTP delivered earnings per share (EPS) of 2 cents in fiscal 2024 compared with break-even EPS at the fiscal 2023-end. Revenues in Detail Elite Pharmaceuticals ...
BALI, INDONESIA, Aug 28, 2023--- The first and only' Elite' Label Road Race event in Indonesia, Maybank Marathon, organized by PT Bank Maybank Indonesia Tbk, took place on Sunday, 27 August 2023 ...
Conference Call Scheduled for Tuesday, July 2 at 11:30 AM EDTNorthvale, New Jersey--(Newsfile Corp. - July 1, 2024) - Elite Pharmaceuticals, Inc. ...
Elite Pharmaceuticals, Inc. ELTP delivered earnings per share (EPS) of 2 cents in fiscal 2024 compared with break-even EPS at the fiscal 2023-end. Elite Pharmaceuticals registered revenues of $56. ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback